{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:37:49Z","timestamp":1781005069888,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejphar.2019.172632","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T19:07:46Z","timestamp":1567105666000},"page":"172632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats"],"prefix":"10.1016","volume":"862","author":[{"given":"Aloke K.","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumava","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banibrata","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lisieski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten E.A.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane A.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172632_bib1","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172632_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ejphar.2019.172632_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0033291715001981","article-title":"The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium","volume":"46","author":"Benjet","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ejphar.2019.172632_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archpsyc.1991.01810270028003","article-title":"Traumatic events and posttraumatic stress disorder in an urban population of young adults","volume":"48","author":"Breslau","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib5","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.91.26.12584","article-title":"Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium","volume":"91","author":"Buck","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172632_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/syn.21538","article-title":"Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder","volume":"66","author":"Bymaster","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2019.172632_bib7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.05.008","article-title":"D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action","volume":"589","author":"Dutta","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2011.09.162","article-title":"The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents","volume":"671","author":"Dutta","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113420","article-title":"Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters","volume":"9","author":"Dutta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172632_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2015.02.027","article-title":"Single prolonged stress effects on sensitization to cocaine and cocaine self-administration in rats","volume":"284","author":"Eagle","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2019.172632_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2016.11.048","article-title":"Considering future pharmacotherapy for PTSD","volume":"649","author":"Friedman","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2019.172632_bib15","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","article-title":"Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence","volume":"269","author":"Gu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172632_bib16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2174\/138945009789735156","article-title":"Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors","volume":"10","author":"Guiard","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2019.172632_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","article-title":"Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis","volume":"206","author":"Hoskins","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172632_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/adt.2010.0331","article-title":"Identification of human Ether-a-go-go related gene modulators by three screening platforms in an academic drug-discovery setting","volume":"8","author":"Huang","year":"2010","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejphar.2019.172632_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1017\/S1461145711001209","article-title":"Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)","volume":"15","author":"Ipser","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the national comorbidity survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.024356.111","article-title":"Single prolonged stress disrupts retention of extinguished fear in rats","volume":"19","author":"Knox","year":"2012","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2019.172632_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4530(97)00044-9","article-title":"Stress-restress: effects on ACTH and fast feedback","volume":"22","author":"Liberzon","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2019.172632_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2826.1999.00288.x","article-title":"Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder","volume":"11","author":"Liberzon","year":"1999","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2019.172632_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fpsyt.2018.00196","article-title":"Single-prolonged stress: a review of two decades of progress in a rodent model of post-traumatic stress disorder","volume":"9","author":"Lisieski","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172632_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/157015908787386078","article-title":"Triple reuptake inhibitors: the next generation of antidepressants","volume":"6","author":"Marks","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14740330802423168","article-title":"Paroxetine: safety and tolerability issues","volume":"7","author":"Marks","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2019.172632_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3565(25)22347-3","article-title":"Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats","volume":"270","author":"Masserano","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172632_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/070674370004500509","article-title":"Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians","volume":"45","author":"Mischoulon","year":"2000","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neubiorev.2015.01.019","article-title":"Reward functioning in PTSD: a systematic review exploring the mechanisms underlying anhedonia","volume":"51","author":"Nawijn","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2019.172632_bib31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172632_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0269881106069938","article-title":"The other face of depression, reduced positive affect: the role of catecholamines in causation and cure","volume":"21","author":"Nutt","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/350350a0","article-title":"Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter","volume":"350","author":"Pacholczyk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172632_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","article-title":"Dopaminergic-based pharmacotherapies for depression","volume":"16","author":"Papakostas","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.bjp.0706686","article-title":"Delta opioid receptor ligands modulate anxiety-like behaviors in the rat","volume":"147","author":"Perrine","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12991-019-0232-8","article-title":"Critical appraisal of major depression with suicidal ideation","volume":"18","author":"Pompili","year":"2019","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172632_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.112.193771","article-title":"Novel C-1 substituted cocaine analogs unlike cocaine or benztropine","volume":"343","author":"Reith","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172632_bib39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00213-013-3391-3","article-title":"Evaluation of safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-820836 in healthy subjects: a placebo-controlled, ascending single-dose study","volume":"231","author":"Risinger","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2019.172632_bib40","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172632_bib41","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/cmdc.201200352","article-title":"Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants","volume":"7","author":"Santra","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejphar.2019.172632_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bmc.2014.12.040","article-title":"Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template","volume":"23","author":"Santra","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172632_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bmc.2013.11.017","article-title":"Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: synthesis, biological characterization, and development of a pharmacophore model","volume":"22","author":"Sharma","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172632_bib44","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4155\/fmc.15.134","article-title":"Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?","volume":"7","author":"Sharma","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172632_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(03)01310-4","article-title":"Antidepressant-like actions of DOV 21,947: a \"triple\" reuptake inhibitor","volume":"461","author":"Skolnick","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-3565(25)28163-0","article-title":"Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates","volume":"165","author":"Snyder","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172632_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10401230009147102","article-title":"Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review","volume":"12","author":"Sporn","year":"2000","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2019.172632_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00213-006-0545-6","article-title":"Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats","volume":"189","author":"Takahashi","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2019.172632_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17512433.2017.1260001","article-title":"Novel pharmacological treatment strategies for posttraumatic stress disorder","volume":"10","author":"Thomas","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172632_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2011.09.003","article-title":"Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Tran","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2019.172632_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneumeth.2004.02.022","article-title":"Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex","volume":"137","author":"Williams","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2019.172632_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-0173(83)90005-X","article-title":"Dopamine and depression: a review of recent evidence. I. Empirical studies","volume":"287","author":"Willner","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2019.172632_bib53","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/da.20629","article-title":"Single prolonged stress: toward an animal model of posttraumatic stress disorder","volume":"26","author":"Yamamoto","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2019.172632_bib54","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/jm0601699","volume":"49","author":"Zhang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172632_bib55","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1021\/jm049021k","article-title":"Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner","volume":"48","author":"Zhang","year":"2005","journal-title":"J. Med. Chem."}],"updated-by":[{"DOI":"10.1016\/j.ejphar.2022.175232","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000}},{"DOI":"10.1016\/j.ejphar.2022.175286","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000}}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919305849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919305849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:31:00Z","timestamp":1757975460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919305849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":55,"alternative-id":["S0014299919305849"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172632","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejphar.2022.175232","asserted-by":"object"},{"id-type":"doi","id":"10.1016\/j.ejphar.2022.175286","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172632"}}